W. L. Gore & Associates Enhances GORE® VIABAHN® Endoprosthesis Portfolio With Lower Profile Delivery

Improvements to large diameter devices include accessibility through smaller sheaths while providing enhanced visualization by adding radiopaque markers 25 years of continued innovation PUTZBRUNN, Germany, Sept. 22, 2021 /PRNewswire/ — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore) announced […]

MedAlliance announces completion of enrollment in Japanese SELUTION SLR™ Study

GENEVA, Switzerland, Sept. 22, 2021 /PRNewswire/ — MedAlliance, with its Japanese partner MDK Medical, has completed enrollment in the clinical study of its novel Sirolimus Drug Eluting Balloon (DEB), SELUTION SLR™, for the treatment of peripheral arterial disease (PAD). This follows the acceptance of a Clinical Trial Notification (CTN) by Japan’s Pharmaceutical and Medical Device Agency […]

A World First! Aopeng Medical Completes Human Clinical Trial of Robotic-Assisted Endovascular Intervention for Thoracic and Abdominal Aortic Aneurysm (AAA)

BOSTON, Sept. 21, 2021 /PRNewswire/ — On the morning of September 12, 2021, a complex endovascular intervention was performed at Changhai Hospital of China Naval Medical University by Professor Qing-Sheng Lu’s team using ALLVAS™, China’s first endovascular intervention robot developed by Shanghai Aopeng Medical Technology Co. A total of three patients were treated with ALLVAS™ on that day, […]

Merit Medical Announces Positive Results in First-in-Human Study of WRAPSODY™ Cell-Impermeable Endoprosthesis

Prospective, observational study published in CardioVascular and Interventional Radiology1 reports 100% target lesion primary patency (“TLPP”) rate without reintervention through 30 days, with a 12-month TLPP rate of 84.6% and a 12-month access circuit primary patency (“ACPP”) rate of 65.9%. Authors conclude the results suggest WRAPSODY Endoprosthesis is a safe and […]

Abbott Expands Peripheral Vascular Offerings with Acquisition of Walk Vascular, LLC

Acquisition builds upon Abbott’s leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots ABBOTT PARK, Ill., Sept. 2, 2021 /PRNewswire/ — Abbott (NYSE: ABT) announced today that it has acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood […]

Modern Vascular Raising Awareness of Peripheral Artery Disease and Preventing Amputations for PAD Awareness Month

PHOENIX, Sept. 1, 2021 /PRNewswire/ — Modern Vascular, a pioneering medical group dedicated to preventing amputation through the outpatient treatment of Peripheral Artery Disease (PAD), is marking September PAD Awareness Month at its 16 nationwide clinics by offering screening and treatment for PAD. Experience the interactive Multimedia News Release here: “While PAD […]

Healogics® Raises Awareness of Peripheral Artery Disease (PAD) to Help Reduce Amputations

JACKSONVILLE, Fla., Sept. 1, 2021 /PRNewswire/ — Healogics, the nation’s leading provider of world-class wound care services, is raising awareness of Peripheral Artery Disease (PAD) throughout September. Through this campaign, Healogics is supporting the American Heart Association’s goal to reduce amputations by 20% by 2030 through increased PAD Awareness, diagnosis and treatment. […]

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD

XARELTO® is the first and only therapy indicated for both coronary artery disease (CAD) and PAD, now including PAD patients post-LER XARELTO® is the only anticoagulant in 20 years to show significant benefit in patients with PAD who remain at high risk for major thrombotic events, including acute limb ischemia […]

Shape Memory Medical Announces First Patient Enrollment in the AAA-SHAPE Netherlands Study

SANTA CLARA, Calif.–(BUSINESS WIRE)–Shape Memory Medical Inc., developer of innovative therapies for cardiovascular and neurovascular markets, announced the initiation of AAA-SHAPE Netherlands, the Company’s prospective, multicenter early feasibility study of the IMPEDE-FX RapidFill® Device when used for abdominal aortic aneurysm (AAA) sac management during elective endovascular aneurysm repair (EVAR). The […]

Five-year Results Of The GORE® EXCLUDER® Iliac Branch Endoprosthesis Pivotal U.S. Multicenter Study Confirm Safety, Efficacy and Durability

FLAGSTAFF, Ariz., Aug. 19, 2021 /PRNewswire/ — W. L. Gore & Associates (Gore), today announced that five-year results of the U.S. prospective, multicenter study (N = 63) of endovascular repair of iliac aneurysms using the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) were presented at the 2021 Society for Vascular Surgery Annual Meeting. Results of the […]